Connect with us

Hi, what are you looking for?

World

German safety body must pay 60 mn euros to breast implant victims: court

-

A French court on Friday ordered German safety certifier TUV to pay 60 million euros ($64 million) in compensation to 20,000 women who received defective breast implants that the group had approved.

The German company was ordered to make a provisional payment of 3,000 euros to each plaintiff for certifying that implants made by French firm Poly Implant Prothese (PIP) met safety standards.

In what became a major health scandal, the devices were later found to contain substandard, industrial-grade silicone gel.

"The final amount will be determined after an assessment, but (TUV) is required to make a provisional payment of 3,000 euros" per person, said lawyer Laurent Gaudon, representing 7,000 women.

TUV said it would appeal the latest ruling, issued by a commercial court in the southern port of Toulon.

TUV was found liable in 2013 in a first case brought by 1,700 PIP implant recipients and a group of distributors.

But an appeals court later overturned that decision, saying that TUV had fulfilled its obligations as a certifying body and could not be held responsible for failing to detect PIP's cover-up.

The company maintains it was never its job to check the actual implants, and their task was only to inspect the manufacturing process.

The scandal first erupted in 2010 after doctors noticed abnormally high rupture rates in the implants.

The affair made global headlines in 2011, with some 300,000 women in 65 countries believed to have received the faulty implants.

PIP's founder, Jean-Claude Mas, was convicted of fraud and sentenced to four years in jail in 2013, confirmed on appeal in 2016.

He always denied the implants posed any health risks.

Thousands of women have had the implants removed, despite health officials in several countries saying they are not toxic and are not thought to increase the risk of breast cancer.

A French court on Friday ordered German safety certifier TUV to pay 60 million euros ($64 million) in compensation to 20,000 women who received defective breast implants that the group had approved.

The German company was ordered to make a provisional payment of 3,000 euros to each plaintiff for certifying that implants made by French firm Poly Implant Prothese (PIP) met safety standards.

In what became a major health scandal, the devices were later found to contain substandard, industrial-grade silicone gel.

“The final amount will be determined after an assessment, but (TUV) is required to make a provisional payment of 3,000 euros” per person, said lawyer Laurent Gaudon, representing 7,000 women.

TUV said it would appeal the latest ruling, issued by a commercial court in the southern port of Toulon.

TUV was found liable in 2013 in a first case brought by 1,700 PIP implant recipients and a group of distributors.

But an appeals court later overturned that decision, saying that TUV had fulfilled its obligations as a certifying body and could not be held responsible for failing to detect PIP’s cover-up.

The company maintains it was never its job to check the actual implants, and their task was only to inspect the manufacturing process.

The scandal first erupted in 2010 after doctors noticed abnormally high rupture rates in the implants.

The affair made global headlines in 2011, with some 300,000 women in 65 countries believed to have received the faulty implants.

PIP’s founder, Jean-Claude Mas, was convicted of fraud and sentenced to four years in jail in 2013, confirmed on appeal in 2016.

He always denied the implants posed any health risks.

Thousands of women have had the implants removed, despite health officials in several countries saying they are not toxic and are not thought to increase the risk of breast cancer.

AFP
Written By

With 2,400 staff representing 100 different nationalities, AFP covers the world as a leading global news agency. AFP provides fast, comprehensive and verified coverage of the issues affecting our daily lives.

You may also like:

Business

Meta's growth is due in particular to its sophisticated advertising tools and the success of "Reels" - Copyright AFP SEBASTIEN BOZONJulie JAMMOTFacebook-owner Meta on...

Tech & Science

AI and ML are streamlining clinical trials, delivering validated real-time data to decision-making teams faster and with more accuracy.

World

The world's biggest economy grew 1.6 percent in the first quarter, the Commerce Department said.

World

Former US President Donald Trump attends his trial for allegedly covering up hush money payments linked to extramarital affairs - Copyright AFP PATRICIA DE...